Date:November 14, 2012

Andras Heczey, MD

Andras Heczey, M.D.Director, Liver Tumor Program

Assistant Professor
Department of Pediatrics
Section of Hematology-Oncology,
Baylor College of Medicine

Dr. Andras Heczey
Texas Children’s Cancer Center
1102 Bates Street, Suite 1230.06
Houston, TX 77030

Clinic: 832-822-4240
Office: 832-824-4233
Fax: 832-825-1453


About Andras Heczey, MD

Dr. Andras Heczey is a physician-scientist and full-time faculty in the Department of Pediatrics of Baylor College of Medicine, Section of Pediatric Hematology and Oncology. He is a member of the multidisciplinary solid tumor team and the Center for Cell and Gene Therapy (CAGT).

His research focuses on developing novel treatments for children with solid tumors by redirecting the immune system to attack cancer cells.

Dr. Heczey has studied and published the first adoptive immunotherapy approach utilizing Natural Killer T cells genetically modified to attack neuroblastoma, he is working on moving this approach from bench-to-bedside in a form of a Phase 1/2a clinical trial.

As the Director of the Liver Tumor Center, Dr. Heczey has developed a strategy to target hepatoblastoma and hepatocellular carcinoma with genetically engineered T lymphocytes and he is currently optimizing this strategy for a smooth transition into the clinic.

Dr. Heczey is a member of the Bone Marrow Transplant (BMT) / Stem Cell Transplant Program,  the Liver Tumor Program, and the Neuroblastoma Program.


M.D., Semmelweiss University, Budapest, Hungary
Residency, Children’s Hospital of Los Angeles
Fellowship, Pediatric Hematology/Oncology. Baylor College of Medicine

Selected Memberships

Member, American Society of Clinical Oncology (ASCO)
Member, American Society of Pediatric Hematology and Oncology (ASPHO)
Member, Children’s Oncology Group (COG)

Positions and Honors

Good Student and Good Athlete of the Republic of Hungary 2000. From the Ministry of Education of Hungary

Associates and Affiliates Award of the Children’s Hospital of Los Angeles, 2009, For scientific knowledge, clinical judgment and excellence in human relations
Tumor Board Award, 2010, Texas Children’s Cancer d Hematology Centers
Chief Fellow, 2011-2012, Texas Children’s Cancer and Hematology Centers
Fellows’ Excellence in Education Award, 2015, Texas Children’s Cancer and Hematology Centers